Motiva Flora® Aesthetic Breast Recon® Clinical Study

The present study will be based on a hybrid breast reconstruction approach with initial skin expansion using the Motiva Flora® Tissue Expander followed by a serial fat grafting session and a final step that includes the placement of a permanent breast implant Ergonomix2®.

Trial Details

NCT ID
NCT06146231
Phase
NA
Sponsor
Establishment Labs
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Motiva Flora® Tissue Expander
Locations (sample)
  • Ghent, Belgium|51.05,3.71667
  • Bogotá, Colombia|4.60971,-74.08175
  • San José, Costa Rica|9.93388,-84.08489
  • Barcelona, Spain|41.38879,2.15899

Key Eligibility Criteria

  • Genetically female, aged 18 years or older.
  • Subjects who had provided written informed consent form.
  • The participant needs tissue expansion as part of breast reconstruction treatment, which may include immediate reconstruction.
  • Clinical condition to allow reverse expansion breast reconstruction, at the investigator's discretion.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →